Simulations Plus, Inc. Declares Quarterly Cash Dividend, Payable on February 2, 2018
January 16, 2018 at 03:30 pm
Share
Simulations Plus, Inc. announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.06 per share to its shareholders. The cash dividend will be distributed on February 2, to shareholders of record as of January 26, 2018.
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. The Company also provides tech-enabled training and compliance solutions for clinical trial investigators and site staff.